Physician profile
Kenneth C Civello
NPI 1699745562
$29,568.02
in general payments reported to CMS, 2019-2025
49 companies · $980 in 2025
The $980 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $4,514 · 2021: $1,126 · 2022: $6,250 · 2023: $1,041 · 2024: $2,628 · 2025: $980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,724 · Travel and Lodging: $924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,724.09 |
| Travel and Lodging | $924.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $11,559.71 | 2019-2020 | |
| Medtronic, INC. | $8,111.24 | 2021-2025 | Achieve, Na, Linq II |
| Atricure, INC. | $3,496.57 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Boston Scientific Corporation | $1,007.92 | 2019-2025 | Cds - Mct/Cem Monitoring, Watchman Flx, Patientcare Link |
| Janssen Pharmaceuticals, INC | $924.03 | 2019-2024 | Xarelto |
| Pfizer INC. | $690.27 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $464.19 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $383.25 | 2019-2025 | |
| Abbott Laboratories | $357.50 | 2019-2025 | Aveir, Jot Dx |
| Kestra Medical Technology Services, INC. | $259.70 | 2022-2025 | Assure Wcd |
| Irhythm Technologies, INC. | $249.01 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| E.R. Squibb & Sons, L.L.C. | $196.01 | 2019-2025 | Camzyos |
| Amgen INC. | $190.06 | 2019-2025 | Repatha, Repatha |
| Biotronik INC. | $156.84 | 2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Astrazeneca Pharmaceuticals LP | $152.14 | 2020-2025 | Farxiga |
Show all 48 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Civello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.